![Top Five BioPharma Adopts LifeSphere MultiVigilance to Automate Drug Safety](https://www.arisglobal.jp/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Global life sciences leader will deploy ArisGlobal’s next-generation safety system, leveraging cognitive automation to streamline case processing. Miami, Florida, 3…
Learn More![Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection](https://www.arisglobal.jp/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Luye Pharma Group, an international pharmaceutical has selected LifeSphere Signal and Risk Management as its next-generation signal detection tool.
Learn More![Two Top 25 Global Pharma Companies Adopt LifeSphere® Intake and Triage to Automate Adverse Event Case Processing](https://www.arisglobal.jp/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Two large multi-national pharmaceutical companies have selected the LifeSphere® Intake and Triage solution to bring substantial efficiency gains to adverse event case processing across their global affiliates
Learn More![ArisGlobal’s LifeSphere MultiVigilance Goes Live with Top 5 Pharma, Delivering a Next-Generation Safety System to 2,300+ End Users](https://www.arisglobal.jp/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
ArisGlobal successfully delivered the industry’s largest drug safety system implementation, going live on-time with its next-generation LifeSphere® MultiVigilance offering. LifeSphere MultiVigilance 10 is the industry’s only end-to-end safety system offering production-ready automation.
Learn More![10 Life Sciences Companies Switch to ArisGlobal’s LifeSphere® MultiVigilance from Competing Safety Systems](https://www.arisglobal.jp/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
ArisGlobal is proud to announce that ten life sciences companies have switched to its industry-leading LifeSphere® MultiVigilance drug safety system within the past 12 months. LifeSphere MultiVigilance is a next-generation, end-to-end safety system that has been developed in close partnership with industry leaders, including the FDA, Boehringer Ingelheim, Teva and AbbVie, among others.
Learn More![ArisGlobal Releases Comprehensive Automated Literature Monitoring Solution for Improved Pharmacovigilance](https://www.arisglobal.jp/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
ArisGlobal, the visionary technology provider of automated solutions for the life sciences industry, today announced the availability of LifeSphere® LitPro (LSLP), the life science industry’s first and only solution that effectively automates all steps in the medical literature monitoring (MLM) process required by most regulatory agencies.
Learn More![ArisGlobal Announces LifeSphere® MultiVigilance 10, Industry’s First End-to-End Safety System with Production-Ready Automation](https://www.arisglobal.jp/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
ArisGlobal, the visionary provider of drug development technology for the life sciences industry, today announced the availability of LifeSphere® MultiVigilance 10 (LSMV10), the industry’s only end-to-end drug safety system with production-ready automation.
Learn MoreSanten Pharmaceutical Co., Ltd., the leader in ophtalmicdrug development, has selected ArisGlobal to create a single global safety database and improve the efficiency and quality of their global safety vigilance processes. Santen Pharmaceutical’s safety suite will include ArisGlobal’s LifeSphere® MultiVigilance (LSMV), LifeSphere® Reporting and Analytics and LifeSphere® Intake and Triage solutions to automate key safety vigilance activities, reduce costs, and increase compliance.
Learn More![ArisGlobal Will Showcase New Automation Solutions and Strategies to Industry Leaders at 2019 Life Sciences Technology Summit](https://www.arisglobal.jp/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
ArisGlobal today announced details of its annual Life Sciences Technology Summit (AGLSTS 2019), taking place October 1st – 3rd at the Miami Beach EDITION hotel in Miami Beach, Florida. The 3-day event will bring together senior executives, IT and business practitioners, and industry experts across drug safety, regulatory affairs, clinical development, and medical affairs to discuss how a unified platform and automation technology can transform the drug development process.
Learn More![ArisGlobal Safety Expert to Present “How to Fully Leverage Automation in PV – A Real Case Study” at World Drug Safety Congress Europe](https://www.arisglobal.jp/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
ArisGlobal, LLC, a leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, will present a session titled “How to Fully Leverage Automation in PV – A Real Case Study” at the upcoming World Drug Safety Congress Europe 2019, September 10-11, 2019 at the Hotel Hilton Amsterdam, Amsterdam, Netherlands.
Learn More